Sowell Financial Services’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-45
| Closed | – | – | 2972 |
|
|
2021
Q1 | $0 | Sell |
45
-12,535
| -100% | – | ﹤0.01% | 3370 |
|
|
2020
Q4 | $42K | Buy |
12,580
+12,500
| +15,625% | +$41.7K | ﹤0.01% | 1466 |
|
|
2020
Q3 | $0 | Sell |
80
-2,283
| -97% | – | ﹤0.01% | 2777 |
|
|
2020
Q2 | $8K | Buy |
2,363
+2,283
| +2,854% | +$7.73K | ﹤0.01% | 1786 |
|
|
2020
Q1 | $0 | Hold |
80
| – | – | ﹤0.01% | 2772 |
|
|
2019
Q4 | $0 | Hold |
80
| – | – | ﹤0.01% | 2709 |
|
|
2019
Q3 | $1K | Buy |
+80
| New | +$1K | ﹤0.01% | 2346 |
|